A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients

NCT03602911 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: The isotope 68Ga, NETSPOT and 18F-FDG-PET/CT

Sponsor

West Virginia University